Lipidomic response to coffee consumption
. Baseline characteristics of coffee trial participants (N=47) 98.1 (10.5) 141 (15) 90 (9) 2 (4) 4.0 (1.7)
17 (36) Data are mean (SD) unless otherwise noted *Listed are 82 metabolites of known identity associated with coffee response from our previous metabolomics analysis of these coffee trial samples{Cornelis, 2018 #8582}. These metabolites were measured by UPLC-ESI-MS/MS (nontargeted) and processed as previously described{Cornelis, 2018 #8582}. Mass spectral peaks, retention times, and m/z were used to determine the relative quantities of each metabolite. Twenty-four of these 82 were also lipids but are herein referred to as 'metabolites' to distinguish them from the new lipid species data. ‡Colors correspond to color scheme used in Figure S3 . ‡Includes fasting status at time of specimen collection, year of blood/urine collection, and platform used for metabolomic profiling (if reported). §Population ancestry: EU European, AA African American; Sex: M male, F female Shown are studies applying metabolomic platforms with potential for lipid detection. Annotation for PCs: "aa" indicates that both moieties at the sn-1 and sn-2 position are fatty acids and bound to the glycerol backbone via ester bonds. "ae" denotes that one of the moieties, either in the sn-1 or at sn-2 position is a fatty alcohol and bound via an ether bond. Total number of carbon atoms and double bonds present in both lipid fatty acid chains are denoted as "C x:y", where x is the total carbon number of both chains and y is the total number of double bonds. Annotation for SMs: Total number of carbon atoms, the number of double bonds or the presence of hydroxyl group (OH) are indicated only for the fatty acid in the amide bond under assumption that the backbone is formed by sphingosine (d18:1). Total number of carbon atoms and double bonds present in fatty acid chain is denoted as "C x:y", where x is the carbon number and y is the number for double bonds Obesity/BMI [15, 16] CRP [16] HCC [17] CVD [18] T2D & related traits [19] Breat Ca [20] Prostate Ca [20] CRC [20] T2D & related traits [21, 22] CVD [23, 24] Obesity/BMI [22] LPC(17:0)
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Lung Ca [34] Obesity/BMI [35] Ovarian Ca [37] Huntington's [51] Weight loss <100 [16] HCC 200 [17] CVD [18] Breat Ca [20] Prostate Ca [20] CRC [20] CVD [23, 24] Obesity/BMI [30, 39] T2D & related traits [27, 28] [31] Aging [31] Lung Ca [34] Depression [53] Ovarian Ca [44] Obesity/BMI [15, 16] Weight loss/RYGB [16, 54] CRP [16] Lung function [55] T2D & related traits [21] CVD [45] CRC [46] AD/Cognition [56] Obesity/BMI [48] T2D & related traits [48] HTN/BP [48] CVD [24] Ovarian Ca [50] *Shown are results from a non-comprehensive literature search for human clinical or observational studies relating circulating lysophosphatidylcholine with coffee-implicated disease or conditions [57] . Lipid pathway including neutral and phospholipid lipid classes measured (circle nodes) in the current study. Lipid classes with lipid species that increased and decreased in response to coffee intake are colored red and green, respectively. Lipid classes with lipid species that increased or decreased are colored yellow. See Table 1 for details. CDP-DAG, CDP-diacylglycerol; CE, cholesteryl ester; CHOL, cholesterol; CL, cardiolipin; DAG, diacylglycerol; DHAP, dihydroxyacetone phosphate; FFA, free fatty acid; G3P, glycerol-3-phosphate; PA, phosphatic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; LCL, lysocardiolipin; LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPG, lysophosphatidylglycerol; LPI, lysophosphatidylinositol; LPS, lysophosphatidylserine; MAG, monoacylglycerol; TAG, triacylglycerol. [58] .
